Xylapan, 20 mg/ml süstelahus
Xylapan, 20 mg/ml süstelahus
Authorised
- Xylazine hydrochloride
Product identification
Medicine name:
Xylapan, 20 mg/ml süstelahus
Active substance:
- Xylazine hydrochloride
Target species:
-
Horse
-
Cattle
-
Dog
-
Cat
Route of administration:
-
Intravenous use
-
Intramuscular use
Product details
Active substance and strength:
-
Xylazine hydrochloride23.32/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intravenous use
- Horse
-
Meat and offal1day
-
Milk0day
-
-
Intramuscular use
- Cattle
-
Meat and offal1day
-
Milk0day
-
- Dog
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN05CM92
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Package description:
- Available only in Estonian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Vetoquinol Biowet Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
- Vetoquinol Biowet Sp. z o.o.
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1298
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 22/12/2021
How useful was this page?:
